Cardioprotective Actions of a Glucagon-like Peptide-1 Receptor Agonist on Hearts Donated After Circulatory Death.

Improvements in systolic function, as represented by maximum first derivative of LV pressure (Max +dp/dt: 2317±300 versus 1949±664 mm Hg/s, P =0.22), left ventricular ejection fraction by pressure‐volume loops (46±13 versus 33%±9%, P =0.05), and by echocardiography (60±8 versus 43%±21%, P =0.08), failed to reach statistical significance (Figure 4 ).

also in 6,035 other papers